Rua receives bridging capital

Tairawhiti, New Zealand – Rua Bioscience (NZX: RUA ) has decided to place new shares with key shareholders as part of a capital raise aimed at meeting short-term working capital requirements.

The company has secured $150,000 through this targeted raise.

This is part of Rua Bioscience’s broader financial strategy to ensure sufficient cash flow for its immediate needs while continuing to execute its growth plans in key markets. The funds will bridge the gap until the finalisation of the recent manufacturing facility sale, allowing Rua to focus on scaling its sales efforts in key international markets, particularly Germany, Australia and UK.

Chair Anna Stove stated, “This capital raise demonstrates the strong backing from our core shareholders and their confidence in Rua’s strategic direction. It enables us to maintain our operational momentum and ensure we have the necessary resources to meet our immediate working capital needs as we drive significant sales growth and sustainable revenue in FY25.”

ENDS

• Rua receives bridging capital
• Corporate Action Notice

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Ryman finalises repayment of debt facilities
AIA - DRP Strike Price and AUD FX Rate for 1H25 dividend
NZ King Salmon Investments Ltd releases FY25 results
CEN - Contact to appeal Southland Wind Farm decision
KMD - 1H FY2025 Interim Results
TEM - Cancellation of Treasury Shares
Meridian to proceed with $227m Ruakākā Solar Farm
SDL - Solution Dynamics Buyback and Guidance
March 25th Morning Report
TruScreen to Present at Singapore Healthcare Day Forum